Keywords: lilly, 1st-qtr, profit, jumps, 31b, drug, major
Lilly's 1st-qtr profit jumps 23.6% to $1.31B
Article | 29 April 2009
US drug major Eli Lilly's first-quarter 2009 profit rose 23.6% year-on-year to $1.31 billion, as revenues jumped 5% to $5.05 billion, boosted by the strong ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
